Synapse - Wiley Blackwell

Wiley Blackwell

SHERPA: Unknown

People

Herr
Motzer
Brennan
Shah
Danishefsky
Vickers
Russo
Shaha
Eastham
Scardino

Groups

Department of Medicine (1537)
Surgery (1247)
Solid Tumor Oncology Division (893)
Survivorship Research (827)
GSK Faculty (671)
Population Sciences Research Program (628)
Sloan Kettering Institute Faculty (612)
Department of Pathology and Laboratory Medicine (555)
Epidemiology and Biostatistics (494)
Center for Hematologic Malignancies (437)

Search Within

Results (4802)

Export to EndNote / Excel

Tafasitamab plus lenalidomide versus standard of care as second‐line (2L) therapy for patients with R/R DLBCL: A post hoc internal 2L analysis of L‐MIND (IN 2L‐MIND)

Meeting Abstract

Sehn, L. H.; Kuruvilla, J.; Salles, G.; Maddocks, K. J.; Koch, C.; Xue, Z.; Amoloja, T.; Amin, A.; Duell, J.
Hematological Oncology (2023)

Fulltext@MSK | Save

The prognostic value of progressing within 24 months of frontline chemoimmunotherapy (POD24) in relapsed/refractory (R/R) follicular lymphoma (FL)—a SCHOLAR‐5 analysis

Meeting Abstract

Patel, A. R.; Limbrick‐Oldfield, E. H.; Kanters, S.; Ray, M. D.; Best, T.; Ghione, P.; Neelapu, S. S.; Gribben, J. G.; Beygi, S.; Bobillo, S.
Hematological Oncology (2023)

Fulltext@MSK | Save

Treatment outcomes of limited stage grade 3A follicular lymphoma

Meeting Abstract

Sarkar, R. R.; Lee, J.; Zhang, Z.; Zelenetz, A.; Salles, G.; Yahalom, J.; Imber, B.
Hematological Oncology (2023)

Fulltext@MSK | Save

A single‐center experience of low‐dose radiotherapy for primary extranodal marginal zone lymphoma of bronchus‐associated lymphoid tissue (BALT)

Meeting Abstract

Freret, M. E.; Tringale, K. R.; Imber, B. S.; Joffe, E.; Yahalom, J.; Hajj, C.
Hematological Oncology (2023)

Fulltext@MSK | Save

Patterns of disease failure by response to induction therapy in a large cohort of patients with primary central nervous system lymphoma

Meeting Abstract

Tringale, K. R.; Yahalom, J.; Scordo, M.; White, C.; Zhang, Z.; Grommes, C.; Imber, B.
Hematological Oncology (2023)

Fulltext@MSK | Save

Evolving consolidation patterns and modern outcomes for a large longitudinal cohort of primary CNS lymphoma patients

Meeting Abstract

Imber, B. S.; Tringale, K.; White, C.; Zhang, Z.; Scordo, M.; Yahalom, J.; Grommes, C.
Hematological Oncology (2023)

Fulltext@MSK | Save

Radiotherapy as an effective bridge for chemo‐refractory or progressive secondary CNS lymphoma

Meeting Abstract

Cederquist, G.; Tringale, K.; Hajj, C.; Hubbeling, H.; Sarkar, R.; Ma, J.; Dreyfuss, A.; Fregonese, B.; Lee, J.; Salles, G.; more...
Hematological Oncology (2023)

Fulltext@MSK | Save

Brentuximab vedotin, nivolumab, doxorubicin, and dacarbazine for early‐stage classical Hodgkin Lymphoma: Updated results from an ongoing phase 2 study (SGN35‐027 Part C)